Published: 2018-08-25

Association of hyperuricemia and renal involvement in type 2 diabetes mellitus

Rumi Deori, Ratan Kumar Kotokey, Bedanta Bhuyan, Swarnali Devi Baruah


Background: Hyperuricemia maybe an independent risk factor for renal dysfunction in diabetic patients. On the other hand, albuminuria is considered as an indicator for early stages of diabetic nephropathy. The aim of our study was to find out any association between hyperuricemia and simple renal function tests to detect early renal involvement in type 2 diabetes mellitus for its early treatment and prevention for diabetic nephropathy.

Methods: This hospital based cross-sectional study was conducted in 265 patients coming to medicine OPD and IPD in a tertiary care hospital in Assam, India. The subjects included were patients complaining of signs and symptoms of gout with or without Type 2 diabetes mellitus. The subjects were divided into two groups A and B, with and without type 2 diabetes respectively. They were selected randomly under the age group of 20 - 70 years old of both genders. Tests performed were serum uric acid, serum creatinine, blood urea, microalbuminuria, FBS and HbA1c estimated by standard methods.

Results: In both diabetic and non-diabetic group, serum uric acid correlated positively and significantly with serum creatinine (>1.3mg/dl), blood urea (>40mg/dl) and microalbuminuria (p<0.05). Though serum uric acid did not correlate with HbA1c and FBS (p>0.05) in both the group. In non-diabetics, males were 6.95 times likely to have hyperuricemia than females.

Conclusions: Hyperuricemia may be associated with early onset or incipient nephropathy in both diabetes and non- diabetic patient.


Hyperuricemia, Microalbuminuria, Nephropathy, Type 2 diabetes mellitus

Full Text:



American Diabetes Association. Standards of medical care in diabetes: 2011. Diabetes Care 2011;34(Suppl. 1):S11-S61.

Eggers PW. Has the incidence of end-stage renal disease in the USA and other countries stabilized?. Current Opin Nephrol Hyperten. 2011 May 1;20(3):241-5.

Brenner BM, Parving H-H, Mauer M, Ritz E. Diabetic nephropathy. In the kidney. Brenner BM, Ed Philadelphia, WB Saunders, 2004;177-1818.

Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the framingham heart study. Ann Intern Med. 1999;131:7-13.

Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-72:National Health and nutrition examination Survey. JAMA 2000; 283:2404-10.

Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, Lakka TA, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Internal Med. 2004 Jul 26;164(14):1546-51.

Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischaemic stroke mortality: a Chinese cohort study. Arthritis Rheum. 2009;61:225-32.

Ioachimescu AG, Brennan DM, Hoar BM, Kashyap SR, Hoogworf BJ. Serum uric acid, mortality and glucose control in patients with type 2 diabetes mellitus: a PreCIS database study. Diabet Med. 2007;24:1369-74.

Zoppini G, Targher G, Negri C, et al. Elevate serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care. 2009;32:1716-20.

Saggiani F, Pitali S, Targher G, Branzi P, Muggeo M, Bonora E. Serum uric acid and related factors in 500 hospitalized subjects. Metabolism. 1996;45:1557-61.

Fukui M, Tanaka M, Shiraishi E, Harusato I, Hosoda H, Asano M, et al. Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. Metabolism. 2008 May 1;57(5):625-9.

Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?. Am J Med. 2005;118:816-26.

Gersch MS, Johnson RJ. Uric acid and the immune response. Nephrol Dial Transplant. 2006;21:3046-47.

Sanchez-Lozada LG, Nakagawa T, Kang DH, Feig DI, Franco M, Johnson RJ, Herrera-Acosta J. Hormonal and cytokine effects of uric acid. Curr Opin Nephrol Hypertens. 2006;15:30-33.

Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol. 2005;25:39-42.

Lv Q, Meng XF, He FF, Chen S, Su H, Xiong J, Gao P, Tian XJ, Liu JS, Zhu ZH, Huang K, et al. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PloS one. 2013 Feb 20;8(2):e56864.

Bai XU, Tan JB, Feng NI, Sun JP, Zhang KY, Li LI, et al. Association between serum uric acid and prevalence of type 2 diabetes diagnosed using HbA1c criteria among Chinese adults in Qingdao, China. Biomed Environmen Sci. 2015 Dec 1;28(12):884-93.

Qiu Q, Gong Y, Liu X, Dou L, Wang Y, Wang B, et al. Serum uric acid and impaired glucose tolerance: The Cardiometabolic Risk in Chinese (CRC) Study. Cell Biochem Biophysics. 2015 Sep 1;73(1):155-62.

Sluijs I, Beulens JW, van der A DL, Spijkerman AM, Schulze MB, van der Schouw YT. Plasma Uric Acid Is Associated with Increased Risk of Type 2 Diabetes Independent of Diet and Metabolic Risk Factors -3. J Nutrit. 2012 Nov 21;143(1):80-5.

Humans M, Geeraet B, De Keyzer D, Mertens A, Lanoo M, Vanaudenaerde B, et al. Interleukin-1 receptor-associated kinase-3 is a key inhibitor of inflammation in obesity and metabolic syndrome. Plos one 2012;7:e30414.

Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 1977;20:895-900.

Gill A, Kukreja S, Malhotra N, Chhabra N. Correlation of the serum insulin and the serum uric acid levels with the glycated haemoglobin levels in the patients of type 2 diabetes mellitus. Journal of clinical and diagnostic research: JCDR. 2013 Jul;7(7):1295.

Tseng CH. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int. 2005;68:796-801.

Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?. Hypertension. 2003;41(6):1183-90.

Saggiani F, Pilati S, Targher G, Branzi P, Muggeo M, Bonora E. Serum uric acid and related factors in 500 hospitalized subjects. Metabolism. 1996;45: 1557-61.

Mene P, Punzo G. Uric acid: bystander or culprit in hypertension and progressive renal disease? J Hyprtens. 2008;26:2085-92.

Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Eng J Med. 2008 Oct 23;359(17):1811-21.

Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R: Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol. 2008;19:2407-13.

Butler R, Morris AD, Belch JJ, Hill A, Struthers AD: Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension. 2000;35:746-51.

Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, et al. A causal role for uric acid in fructose-induced metabolic syndrome, Am J Physiol Renal Physiol. 2006;290:F625-31.

Bo S, Cavallo‐Perin P, Gentile L, Repetti E, Pagano G. Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest. 2001 Apr;31(4):318-21.

Bonakdaran S, Hami M, Shakeri MT. Hyperuricemia and albuminuria in patients with type 2 diabetes mellitus. Iranian journal of kidney diseases. 2011;5(1):21.

Lin SD, Tsai DH, Hsu SR. Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Asso. 2006 Nov 1;69(11):512-6.

Li Y, Stamler J, Xiao Z, Folsom A, Tao S, Zhang H. Serum uric acid and its correlates in Chinese adult populations, urban and rural, of Beijing. The PRC-USA Collaborative Study in Cardiovascular and Cardiopulmonary Epidemiology. Int J Epidemiol. 1997;26:288-96.

Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Kim H, Rhee EJ, Lee WY. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circulation J. 2005;69(8):928-33.

Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health. 2004;4(1):9.

Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Sari I, et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens. 2006;19:1055-62.

Zoppini G, Targher G, Chonchol M, Ortalda V, Abaterusso C, Pichiri I, et al. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care. 2011:DC_111346.